Continuous glucose monitors (CGMs) are the standard of care for people with insulin-treated diabetes. Yet, despite most states offering some level of CGM coverage through Medicaid, policies are inconsistent nationwide, which can limit access to these life-changing devices. This profile series highlights state innovations for expanding access to CGMs in Medicaid. It is a product of CGM Access Accelerator, a technical assistance and peer learning initiative that is working with Medicaid agencies in seven states — Iowa, Kentucky, Michigan, New Jersey, Oklahoma, South Dakota, and Texas — to expand access to CGMs through Medicaid. The initiative is led by the Center for Health Care Strategies (CHCS) through support from The Leona M. and Harry B. Helmsley Charitable Trust.

Expanding Access to Continuous Glucose Monitors in Kentucky Through Cross-Agency Partnerships – Profiles how Kentucky’s Medicaid and public health agencies used data sharing, policy updates, and targeted outreach to increase access to CGMs and related diabetes supports. The profile offers practical lessons on cross-agency collaboration, coverage alignment, and member and provider engagement to expand CGM use among Medicaid enrollees. (October 2025)

Transforming Diabetes Care with Data: Oklahoma Medicaid’s Continuous Glucose Monitor Policy – Highlights how the Oklahoma Health Care Authority used claims data to identify priority populations, refine coverage criteria, and assess outcomes related to CGM use. The blog post outlines how data-driven insights informed streamlined prior authorization, care management strategies, and how the state plans to further expand CGM access in Medicaid. (September 2025)

Improving Access to Continuous Glucose Monitors for Texans Through Medicaid – Describes how Texas revised its Medicaid coverage criteria and prior authorization processes to align with updated Medicare policy and clinical guidelines for CGM use. The profile details Texas’ policy changes, provider supports, and implementation strategies to broaden CGM access for Medicaid enrollees with diabetes, including those with gestational diabetes. (May 2025)